Across TCGA pan-cancer cohorts, P2RY10BP RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of P2RY10BP’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where P2RY10BP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types P2RY10BP is over-expressed in tumor.
KIRC are the cancer types where P2RY10BP tumor–normal differential expression is most reproducible.